Elotuzumab May Provide Greatest Sustained Relative PFS Benefit in Multiple Myeloma
Four recently approved treatment regimens have demonstrated a PFS benefit for patients with RRMM relative to Rd, but no head-to-head studies have been conducted.
Diagnosis & Disease Information
Melatonin Analogues May Have Antitumor Properties in Melanoma and Breast Cancer
Previous studies have demonstrated that melatonin and its analogues, in addition to their ability to regulate circadian rhythms, may exhibit cytotoxic activity via various cellular mechanisms.
- Loading...
Loading...
Next post in Chemotherapy Foundation Symposium (CFS)
Loading... 
Loading...